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Aim
To illustrate imaging manifestations of unusual side
effects of some new anti-cancer medications.
Many of the new anti-cancer medications target specific
biologic pathways and are expected to cause less adverse
effects on healthy tissues. Some of these agents are asso-
ciated with unusual side effects, recognition of which is
clinically important.
Ipilimumab is a monoclonal antibody against cytotoxic
T lymphocyte-associated antigen (CTLA)-4 used for the
treatment of metastatic melanoma. Though it has been
shown to increase overall survival rates, it also results in
various immune-related adverse effects, one of which is
hypophysitis.
Crizotinib is an anaplastic lymphoma kinase (ALK)
and c-ros oncogene 1 inhibitor, approved for treatment
of non-small cell lung carcinoma. Its side effects include
the unusual formation of complex renal cysts which
mimic renal abscesses or malignancy.
In this presentation, we illustrate the imaging manifesta-
tions of Ipilimumab associated hypophysitis, early recogni-
tion of which is important as cessation of the drug in
affected patients leads to resolution of hypophysitis, and
also demonstrate complex renal cysts associated with the
use of Crizotinib, knowledge of which is important to
avoid misdiagnosis of renal abscess/ malignancy and con-
sequent inappropriate treatment or stoppage of Crizotinib.
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